Latest News

After a weak Q1 performance, is it time to buy Lucid stock?

U.S. Small Business Optimism Index declines to 5-month low in March.

The country’s 40-year path into a debt & deficit spending spiral was not working and had to change dramatically, not gradually, and the process to fix it is scary and uncomfortable.

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

IBM's stock defied market trends with a 13% gain in Q1 2025. Here's how Big Blue pulled off this impressive feat while the S&P 500 struggled.

The U.S. government is fighting another unwinnable war, like fiat money itself is fighting an unwinnable war against gold.

Spruce Point Capital Management has announced a short position against Monster Beverage Corp (NASDAQ:MNST) as the short seller sees 25% to 40% downside risk.

U.S. equity markets are pairing some of their earlier gains. 

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Johnson & Johnson reports long-term efficacy and steroid-sparing benefits of nipocalimab in antibody-positive generalized myasthenia gravis.

Cartesian reports 12-month data for Descartes-08 in myasthenia gravis; Phase 3 AURORA trial expected to begin in Q2 2025.

Delta Air Lines reports Q1 earnings Wednesday. Investors will be looking for consumer demand commentary.

Argenx reports long-term Vyvgart data showing lasting efficacy in gMG and CIDP, with strong safety and symptom control across multiple studies.

China announces 34% tariff on U.S. goods; Trump threatens further hikes. Analysts warn of long-term damage to U.S. tech and auto supply chains.

Bitwise Asset Management introduces 3 new ETFs targeting option income strategies from volatile stocks in the crypto market. Active management by experienced team to capture income and equity gains.

In a Bloomberg Opinion interview, El-Erian noted that the markets are forced to reprice the growth outlook outside the U.S.

Cramer noted that the sell-off is a temporary phenomenon and has nothing to do with concerns of systemic rot in American institutions.